Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AWD-12-353 exerts strong and long-lasting antiinflammatory effects in asthma and COPD

Oct. 14, 2003

New PDE4 inhibitors for inflammation, allergy, etc., under study at Ono

Oct. 10, 2003

Orally active Syk inhibitor exerts antiinflammatory effects in rodent model of asthma

Oct. 9, 2003

4SC presents potassium channel modulators for respiratory disorders and other uses

Oct. 9, 2003

New beta2-adrenoceptor agonists for use in respiratory disorders patented by GSK

Oct. 8, 2003

Novel glucocorticoid agonists developed by GSK researchers

Oct. 8, 2003

Inhaled AWD-12-281 exerts potent bronchodilating effects in animal model of asthma

Oct. 7, 2003

Improved lung function in asthmatics after treatment with roflumilast

Oct. 7, 2003

Antiinflammatory effects of Ono-6126 in healthy volunteers

Oct. 7, 2003

Inhaled ilomastat prevents cigarette smoke-induced lung damage in mouse model of emphysema

Oct. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...